Aurora Financial Journal

CVS Health Corporation (CVS)

NYSE · Consumer staples · Retail-Drug Stores and Proprietary Stores · Financial statements, TTM figures and earnings dates

CVS Health Corporation reported revenue of $415.09B over the trailing twelve months ended June 30, 2026, with net income of $4.89B. Annual financial statements are available for fiscal years 2007 to 2025, taken from the company's filings with the SEC. The next quarterly results release is estimated for October 28, 2026, based on the company's filing history.

Open interactive financials →

Key financials

USDTTM
2026-06-30
FY2025
2025-12-31
FY2024
2024-12-31
FY2023
2023-12-31
FY2022
2022-12-31
FY2021
2021-12-31
Income statement
Revenue$415.09B$402.07B$372.81B$357.78B$322.47B$292.11B
Gross profit–$180.90B$166.52B$140.68B$125.58B$116.31B
Operating income$8.29B$4.66B$8.52B$13.74B$7.95B$13.31B
Net income$4.89B$1.77B$4.61B$8.34B$4.31B$8.00B
Diluted EPS$3.79$1.39$3.66$6.47$3.26$6.02
Cash flow
Operating cash flow$14.78B$10.64B$9.11B$13.43B$16.18B$18.27B
Capital expenditure$3.02B$2.83B$2.78B$3.03B$2.73B$2.52B
Free cash flow$11.76B$7.81B$6.33B$10.39B$13.45B$15.74B
Balance sheet
Cash and equivalents$11.33B$8.45B$8.59B$8.20B$12.95B$9.41B
Total assets$253.77B$253.54B$253.22B$249.73B$228.28B$233.00B
Total liabilities$173.87B$178.16B$177.49B$173.09B$156.51B$157.62B
Total debt$61.41B$64.57B$66.27B$61.61B$52.26B$56.18B
Shareholders' equity$79.70B$75.21B$75.56B$76.46B$71.47B$75.08B

TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in USD as reported; per-share data adjusted for stock splits.

Annual reports

More on the interactive page

The full CVS page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, the statements exactly as filed with the SEC, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.

Open CVS financials →